Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy

Primary Energy Failure Phase (during asphyxia)

• Severe reduction in cerebral blood flow and oxygen availability leads to depletion of adenosine triphosphate (ATP)
• Failure of ATP-dependent Na+/K+ ATPase pumps results in intracellular sodium and water accumulation with cytotoxic edema
• Loss of cellular membrane potential triggers anaerobic metabolism and lactate accumulation, causing intracellular acidosis
• Uncontrolled calcium influx into cells activates destructive intracellular enzymes (proteases, phospholipases, endonucleases)
• Cell death occurs via necrotic mechanisms when ATP depletion is severe

Secondary Energy Failure Phase (reperfusion injury, 6-48 hours post-asphyxia)

• Restoration of cerebral blood flow paradoxically worsens injury through generation of reactive oxygen species (ROS) and reactive nitrogen species
• Mitochondrial dysfunction and oxidative stress trigger apoptotic cell death pathways
• Excitotoxicity occurs through glutamate and aspartate release, activating NMDA and AMPA receptors
• Inflammatory cascade activation includes microglial activation, cytokine release (TNF-α, IL-1β, IL-6), and leukocyte infiltration
• Continued intracellular calcium dysregulation perpetuates cell death
• This phase is theoretically reversible and represents the window for therapeutic intervention

Selective Vulnerability

• Gray matter structures (basal ganglia, thalamus, brainstem) are most severely affected in severe asphyxia ("basal ganglia pattern")
• Watershed zones (parasagittal white matter) are preferentially injured in mild-moderate asphyxia ("watershed pattern")
• Immaturity of neonatal antioxidant defenses and high cerebral metabolic rate contribute to vulnerability
• The immature brain's dependence on anaerobic metabolism limits capacity to tolerate hypoxia

Antepartum Risk Factors

• Maternal infections (chorioamnionitis, maternal sepsis)
• Placental insufficiency (preeclampsia, placental abruption, post-term pregnancy)
• Maternal diabetes or hypertension
• Fetal growth restriction
• Decreased fetal movement

Intrapartum Risk Factors (most critical)

• Umbilical cord complications: nuchal cord, cord prolapse, cord compression
• Placental abruption (sudden and complete)
• Uterine rupture or uterine hyperstimulation
• Prolonged labor or arrest of labor
• Failed instrumented delivery with delayed cesarean section
• Maternal hypotension, anesthesia complications, maternal hemorrhage
• Aspiration of amniotic fluid or meconium
• Intrapartum fetal bradycardia with loss of variability (non-reassuring fetal heart rate tracing)

Neonatal Risk Factors

• Prematurity (paradoxically, extremely preterm infants have lower HIE rates due to lower metabolic demands)
• Meconium-stained amniotic fluid with need for resuscitation
• Apgar scores <5 at 5 minutes (strong predictor)
• Need for resuscitation, including chest compressions or medications

Maternal/Placental Factors

• Intrauterine infections (group B Streptococcus with poor outcomes, cytomegalovirus, toxoplasmosis)
• Maternal cardiac disease, sepsis, or severe anemia
• Placental abnormalities (placenta previa, vasa previa)

Timing and Clinical Course

• Symptoms typically manifest within the first 6-12 hours of life in term or near-term infants
• Extremely preterm infants may present with delayed or subtle findings

Altered Consciousness and Tone (Cardinal Features)

• Altered level of consciousness: hyperalertness progressing to lethargy, stupor, or coma (severity correlates with injury extent)
• Hypotonia or "floppy infant" appearance (early sign, initially diffuse)
• Later development of hypertonia, particularly extensor posturing
• Progressive encephalopathic changes over first 3-5 days of life

Seizures

• Present in approximately 50% of moderate-to-severe HIE cases
• Typically manifest between 12-48 hours of life
• Seizure types include subtle seizures (eye deviation, lip smacking, pedaling motions), clonic seizures (more ominous), or tonic seizures
• Status epilepticus indicates severe injury with worse prognosis
• Seizures represent a marker of severe HIE rather than a primary phenomenon

Autonomic Dysfunction

• Bradycardia and hypotension (may require vasopressor support)
• Irregular respirations, periodic breathing, or apnea requiring mechanical ventilation
• Temperature instability, inability to maintain homeostasis
• Poor feeding reflexes, weak suck, difficulty with oral feeding
• Meconium passage difficulty or retained meconium

Feeding and Gastrointestinal Dysfunction

• Absent or weak suck and swallow reflexes
• Intolerance of enteral feeding
• Increased risk of necrotizing enterocolitis (NEC)
• Gastric distension from ileus

Neurological Examination Findings (Sarnat Staging)

• Stage 1 (Mild): Hyperalertness, normal tone, brisk reflexes, no seizures; prognosis excellent
• Stage 2 (Moderate): Lethargy, mild hypotonia, weak reflexes, seizures common, abnormal Moro reflex; variable prognosis, 80% normal outcome with hypothermia
• Stage 3 (Severe): Stupor/coma, severe hypotonia progressing to hypertonia, weak/absent reflexes, frequent seizures or status epilepticus, minimal suck; poor prognosis, 50-60% mortality or severe disability even with hypothermia

Specific Physical Findings

• Weak or absent Moro reflex (particularly ominous)
• Pupillary abnormalities: miosis (pontine involvement) or mydriasis (increased intracranial pressure)
• Abnormal eye movements: deviation from light stimulus
• Loss of corneal reflex
• Absence of gag reflex

Metabolic Derangements

• Severe metabolic acidosis (pH <7.0, base deficit >16 mEq/L at birth)
• Hypoglycemia or hyperglycemia
• Hyperkalemia from cellular breakdown
• Hypocalcemia
• Hypomagnesemia

Clinical Diagnosis (Requires ALL of the following)

1. 1.Evidence of perinatal asphyxia:

• Umbilical artery pH <7.1 OR base deficit ≥12 mEq/L (indicates metabolic acidosis at birth)
• Apgar score ≤5 at 1 minute AND ≤7 at 5 minutes
• Evidence of fetal distress (non-reassuring heart rate tracing, meconium aspiration)

1. 1.Neonatal encephalopathy within first 72 hours:

• Altered consciousness, abnormal muscle tone, or seizures
• Sarnat staging to classify severity

1. 1.Exclusion of other causes of neonatal encephalopathy:

• Infection (sepsis, meningitis, congenital infection)
• Genetic or metabolic disorders
• Structural CNS abnormalities
• Bleeding disorders or coagulopathy

Laboratory Studies

• Arterial and venous umbilical cord blood gases: essential for diagnosis; metabolic acidosis (base deficit) better correlates with HIE than pH alone
• Serum lactate: elevated lactate (>4 mmol/L) indicates anaerobic metabolism
• Glucose, electrolytes (especially potassium and calcium), magnesium
• Liver function tests: elevated transaminases (ALT/AST) from hepatocellular injury
• Kidney function: elevated creatinine indicating acute kidney injury
• Coagulation studies: PT/INR, aPTT (disseminated intravascular coagulation risk)
• Blood cultures if infection suspected (chorioamnionitis, maternal fever)
• Creatine kinase (CK) and myoglobin if rhabdomyolysis suspected
• Ammonia and amino acid screening if inborn error of metabolism considered

Neurophysiological Studies

• Electroencephalography (EEG): critical prognostic tool
• Normal, continuous background activity suggests good outcome
• Burst suppression or severe abnormality (isoelectric pattern) indicates severe injury and poor prognosis
• Seizures on EEG may not correlate with clinical manifestations (subclinical seizures)
• Early EEG (within 12 hours) prognostically valuable; serial EEGs help track recovery
• Amplitude-integrated EEG (aEEG) provides simplified assessment; lower voltage predicts poor outcome

Neuroimaging

• Cranial ultrasound (cranial US): first-line imaging in unstable infants; can be performed at bedside
• May show early signs of edema, loss of gray-white differentiation
• Limited sensitivity for early changes but can identify hemorrhage or obvious malformations
• Serial ultrasounds may detect progressive changes

• Magnetic resonance imaging (MRI): gold standard for assessing extent and location of injury
• Timing critical: diffusion-weighted imaging (DWI) best at 24-96 hours post-asphyxia
• T1/T2 hyperintensity in basal ganglia and thalamus ("basal ganglia pattern") seen in severe asphyxia
• Watershed white matter injury seen in milder asphyxia
• Apparent diffusion coefficient (ADC) values help assess reversibility
• MRI at 1-2 weeks provides best prognostic information
• Severe MRI findings (extensive abnormality, predominantly gray matter involvement) correlate with poor neurodevelopmental outcome

• Computed tomography (CT): less sensitive than MRI for early ischemic changes; mainly used to exclude hemorrhage or acute complications

Scoring Systems and Prognostic Markers

• Sarnat and Sarnat scoring system: clinical encephalopathy grading (Stage 1-3)
• Thompson score: detailed neurological examination scoring system predicting neurodevelopmental outcome
• Combination of early biomarkers (cord blood lactate, troponin, NSE) with clinical findings improves prognostication but not established as standard

Diagnostic Criteria for HIE (Clinical)

• Perinatal asphyxia (abnormal cord blood gases OR abnormal fetal heart rate tracing OR meconium aspiration with resuscitation)
• Neonatal encephalopathy (Stage 2 or 3 per Sarnat) present within 72 hours of birth
• Absence of alternative diagnoses (infection, metabolic disease, CNS malformation)

Initial Management and Stabilization

• Optimize cardiovascular stability: maintain normal heart rate (100-160 bpm), blood pressure in age-appropriate range
• Maintain adequate oxygenation (target SpO₂ 90-95% for term infants; higher in preterm) and ventilation without excessive supplemental oxygen (hyperoxia worsens injury)
• Maintain normothermia (avoid both hypothermia and hyperthermia) during initial stabilization; passive cooling acceptable while preparing for active cooling
• Assess for need for resuscitation: skilled resuscitation team present at delivery, equipment readily available
• Cord milking in severely compromised infants may increase placental transfusion

Primary Neuroprotective Therapy: Therapeutic Hypothermia

• Mechanism: reduces cerebral metabolic rate, decreases excitotoxicity, reduces inflammatory cascade, reduces ROS production, decreases apoptosis
• Indications: moderate-to-severe neonatal encephalopathy (Sarnat Stage 2-3) in infants ≥35 weeks gestation with evidence of perinatal asphyxia
• Timing: CRITICAL - must be initiated within 6 hours of birth (ideally <3 hours) for efficacy; minimal benefit if started after 6 hours
• Methods:
• Selective head cooling: cooling cap applied to head with whole-body temperature maintenance at 34-35°C; may allow continued peripheral perfusion
• Whole-body cooling: core temperature reduced to 33-34°C using ice packs, cooling blankets, or intravascular cooling devices
• Duration: 72 hours of cooling, then gradual rewarming at 0.5°C per hour
• Efficacy: Number needed to treat (NNT) approximately 7 to prevent one case of death or disability; reduces adverse outcome risk by ~27%
• Monitoring: continuous core temperature monitoring, EEG monitoring recommended, frequent vital signs, frequent neurological assessments

Seizure Management

• First-line antiepileptic: Phenobarbital (loading dose 20 mg/kg IV, followed by maintenance 3-4 mg/kg/day divided BID-QID)
• Mechanism: enhances GABA inhibitory neurotransmission
• Rapid onset of action
• Minimal interaction with hypothermia
• Monitor serum levels (therapeutic 15-40 mcg/mL)

• Second-line agents:
• Levetiracetam (loading 10-20 mg/kg IV, maintenance 20-40 mg/kg/day divided BID): increasing evidence of efficacy, fewer drug interactions
• Phenytoin (loading 20 mg/kg IV, slower onset): less preferred due to altered pharmacokinetics in hypothermia, drug interactions
• Pyridoxamine: trial in HIE showing potential benefit, mechanism unclear, may help refractory seizures
• Lorazepam or midazolam for acute seizure termination or status epilepticus

• Continuous EEG monitoring essential to detect subclinical seizures (occur in 50% of moderate-severe HIE cases)
• Seizure prophylaxis (phenobarbital to all severe HIE) may be considered by some centers though evidence mixed

Supportive Care and Management of Complications

• Respiratory support: maintain PaCO₂ 40-45 mmHg; avoid hypocapnia (causes cerebral vasoconstriction) and hypercapnia (worsens acidosis)
• Hemodynamic support:
• Maintain normal blood pressure (hypotension worsens ischemia, hypertension increases ICP)
• Dopamine (5-10 mcg/kg/min) or dobutamine (5-10 mcg/kg/min) for hypotension refractory to fluid resuscitation
• Normal saline boluses (10 mL/kg) for hypovolemia
• Minimize sedation if possible to allow neurological assessment; use minimal doses if required

• Glucose management:
• Maintain normoglycemia (target 80-150 mg/dL); avoid hypoglycemia (worsens injury) and hyperglycemia (increases inflammation)
• IV dextrose for hypoglycemia, reduce glucose infusion if hyperglycemia develops

• Electrolyte management:
• Careful correction of hypokalemia (may require sequential labs given ongoing cellular lysis)
• Calcium supplementation for hypocalcemia
• Magnesium repletion if low

• Infection prevention and treatment:
• Blood cultures at admission if maternal chorioamnionitis or intrapartum fever
• Empiric antibiotics (ampicillin + gentamicin ± ac

Multiorgan injury (asphyxia is never brain-only)

• Acute kidney injury: the kidney is the most commonly injured non-neural organ because diving-reflex redistribution sacrifices renal flow; acute tubular necrosis presents as oliguria, rising creatinine, and muddy-brown casts. Superimposed SIADH produces hyponatremia with concentrated urine — fluid restriction, not saline loading, is the answer.
• Myocardial dysfunction: subendocardial and papillary muscle ischemia cause tricuspid regurgitation, elevated troponin, and cardiogenic shock; signaled by hypotension unresponsive to volume.
• Persistent pulmonary hypertension of the newborn: hypoxia and acidosis keep pulmonary vascular resistance high, producing right-to-left ductal shunting. Emergency — the tell is a pre-/post-ductal saturation gradient with labile hypoxemia; treat with lung recruitment, correction of acidosis, and inhaled nitric oxide.
• Hepatic injury and coagulopathy: transaminase elevation, hypoglycemia from depleted glycogen, and DIC with pulmonary or intracranial hemorrhage. Emergency if bleeding.
• Necrotizing enterocolitis: mesenteric ischemia plus early enteral feeding; abdominal distension with pneumatosis intestinalis on radiograph is an emergency.
• Refractory status epilepticus and cerebral edema: worsening burst suppression, bulging fontanelle, and pupillary changes signal herniation risk — an emergency.

Complications of therapeutic hypothermia (per AAP clinical guidance and the cooling trials)

• Sinus bradycardia: expected and benign at target temperature; do not treat or abort cooling for it.
• Thrombocytopenia and prolonged clotting times: cold-impaired platelet function and enzyme kinetics; watch for oozing at line sites.
• Altered drug pharmacokinetics: reduced hepatic clearance raises levels of phenobarbital, morphine, and gentamicin — monitor levels.
• Subcutaneous fat necrosis: firm violaceous plaques over back and shoulders appearing weeks later, with hypercalcemia that can be symptomatic; check calcium in any cooled infant with these lesions.
• Rewarming injury: vasodilation with hypotension, hyperkalemia, hypoglycemia, and rebound seizures; rewarm slowly and keep continuous EEG. Overshoot hyperthermia is an emergency — fever worsens neuronal injury.

• The 6-hour window is the whole question: for a term or near-term infant with moderate-to-severe encephalopathy, the single best next step is initiating therapeutic hypothermia — not obtaining MRI, not a lumbar puncture, not a metabolic workup. Imaging and labs proceed in parallel; nothing delays cooling.
• Cooling is the only proven neuroprotectant. Erythropoietin, magnesium, allopurinol, and steroids are not standard adjuncts; a stem offering "add erythropoietin to hypothermia" is a distractor.
• Low Apgar alone is not HIE. The ACOG/AAP consensus on neonatal encephalopathy requires an encephalopathy syndrome plus supportive evidence (metabolic acidosis on cord gas, a sentinel event, an abnormal fetal heart rate pattern) and exclusion of mimics. Apgar scores were never designed to diagnose asphyxia or assign causation.
• Injury pattern maps to insult type: acute profound asphyxia (cord prolapse, uterine rupture) injures the metabolically active deep gray — posterolateral putamen, ventrolateral thalamus, perirolandic cortex — and predicts dyskinetic cerebral palsy with relatively preserved cognition. Partial prolonged hypoxia injures parasagittal watershed cortex and white matter, predicting cognitive and visual deficits. This is the association examiners test.
• DWI pseudonormalization is the classic imaging trap: diffusion restriction peaks in the first few days and can look deceptively normal around the end of the first week. A "normal" late DWI does not exclude injury — use conventional T1/T2 sequences and MR spectroscopy (elevated lactate, reduced NAA).
• Seizures are usually subclinical. Because electroclinical dissociation is common and phenobarbital uncouples further, continuous EEG or aEEG is required; treating only what you see undercounts the burden. Phenobarbital remains first-line, with levetiracetam as an alternative.
• Don't cool the wrong patient: hypothermia is validated for infants ≥35–36 weeks with Sarnat stage 2–3. Mild (stage 1) encephalopathy and preterm infants fall outside trial criteria.
• Hyperthermia at any point worsens outcome — including passive overheating on the radiant warmer during resuscitation.